J9289 – Injection, nivolumab, 2 mg and hyaluronidase-nvhy
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9289
- Long description
- Injection, nivolumab, 2 mg and hyaluronidase-nvhy
- Short description
- Inj nivolumab 2 mg hyaluron
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1DChemotherapy- ASC
- Approved for ambulatory surgical centers
- Added
- July 1, 2025
- Last change
- July 1, 2025 – No change
Frequently asked questions
What is HCPCS code J9289?
J9289 is a HCPCS Level II code for injection, nivolumab, 2 mg and hyaluronidase-nvhy.
Does Medicare cover J9289?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9276 – Injection, zanidatamab-hrii, 2 mg
- J9277 – Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph
- J9278 – Injection, carboplatin (avyxa), 1 mg
- J9280 – Injection, mitomycin, 5 mg
- J9281 – Mitomycin pyelocalyceal instillation, 1 mg
- J9282 – Mitomycin, intravesical instillation, 1 mg
- J9285 – Injection, olaratumab, 10 mg
- J9286 – Injection, glofitamab-gxbm, 2.5 mg
- J9292 – Injection, pemetrexed dipotassium, 10 mg
- J9293 – Injection, mitoxantrone hydrochloride, per 5 mg
- J9294 – Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg
- J9295 – Injection, necitumumab, 1 mg
- J9296 – Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg
- J9297 – Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg
- J9298 – Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg
- J9299 – Injection, nivolumab, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.